These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 6689702

  • 1. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL, Tindall GT, Kovacs K, Thorner MO, Horvath E, Hoffman JC.
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [Abstract] [Full Text] [Related]

  • 2. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
    Hubbard JL, Scheithauer BW, Abboud CF, Laws ER.
    J Neurosurg; 1987 Dec; 67(6):816-21. PubMed ID: 3681421
    [Abstract] [Full Text] [Related]

  • 3. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM, Bevan JS, Burke CW, Adams CB.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [Abstract] [Full Text] [Related]

  • 4. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM, Gancel A, Weinstein A, Courtois H, Schrub JC, Tadie M, Wolf LM.
    Presse Med; 1985 Mar 02; 14(9):525-8. PubMed ID: 3157164
    [Abstract] [Full Text] [Related]

  • 5. Bromocriptine therapy as pre-operative adjunct of non-functional pituitary macroadenomas.
    Zárate A, Morán C, Klériga E, Loyo M, González-Angulo A, Aquilar-Parada E.
    Acta Endocrinol (Copenh); 1985 Apr 02; 108(4):445-50. PubMed ID: 3993311
    [Abstract] [Full Text] [Related]

  • 6. Rapid regression of pituitary prolactinomas during bromocriptine treatment.
    Thorner MO, Martin WH, Rogol AD, Morris JL, Perryman RL, Conway BP, Howards SS, Wolfman MG, MacLeod RM.
    J Clin Endocrinol Metab; 1980 Sep 02; 51(3):438-45. PubMed ID: 6773972
    [Abstract] [Full Text] [Related]

  • 7. [Pathological changes of prolactinomas treated with bromocriptine].
    Teramoto A, Takakura K, Fukushima T, Osamura Y.
    No Shinkei Geka; 1982 Jun 02; 10(6):619-27. PubMed ID: 7121729
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors.
    Laws ER, Fode NC, Randall RV, Abboud CF, Coulam CB.
    J Neurosurg; 1983 May 02; 58(5):685-8. PubMed ID: 6834116
    [Abstract] [Full Text] [Related]

  • 12. Management of prolactinomas associated with very high serum prolactin levels.
    Barrow DL, Mizuno J, Tindall GT.
    J Neurosurg; 1988 Apr 02; 68(4):554-8. PubMed ID: 3351583
    [Abstract] [Full Text] [Related]

  • 13. Bromocriptine treatment reduces the cell size in human macroprolactinomas: a morphometric study.
    Bassetti M, Spada A, Pezzo G, Giannattasio G.
    J Clin Endocrinol Metab; 1984 Feb 02; 58(2):268-73. PubMed ID: 6693536
    [Abstract] [Full Text] [Related]

  • 14. Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis.
    Mori H, Mori S, Saitoh Y, Arita N, Aono T, Uozumi T, Mogami H, Matsumoto K.
    Cancer; 1985 Jul 15; 56(2):230-8. PubMed ID: 4005795
    [Abstract] [Full Text] [Related]

  • 15. Perivascular fibrosis in prolactinomas: is it increased by bromocriptine?
    Landolt AM, Osterwalder V.
    J Clin Endocrinol Metab; 1984 Jun 15; 58(6):1179-83. PubMed ID: 6725514
    [Abstract] [Full Text] [Related]

  • 16. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
    Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, Joplin G, Robbins RJ, Tyson J, Thorner MO.
    J Clin Endocrinol Metab; 1985 Apr 15; 60(4):698-705. PubMed ID: 3882737
    [Abstract] [Full Text] [Related]

  • 17. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M, Simionescu N, Oprescu M, Alessandrescu D.
    Endocrinologie; 1983 Apr 15; 21(3):157-68. PubMed ID: 6635518
    [Abstract] [Full Text] [Related]

  • 18. [Histological changes and operative findings of pituitary adenomas after bromocriptine treatment].
    Takahashi T, Kuwayama A, Katoh T, Kageyama N.
    Nihon Naibunpi Gakkai Zasshi; 1986 Dec 20; 62(12):1336-51. PubMed ID: 3817228
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
    Schettini G, Lombardi G, Merola B, Miletto P, Fariello C, Cirillo S, Fusco R, Lancranjan I.
    J Endocrinol Invest; 1988 Jan 20; 11(1):47-51. PubMed ID: 3361075
    [Abstract] [Full Text] [Related]

  • 20. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
    Montini M, Pagani G, Gianola D, Pagani MD, Salmoiraghi M, Ferrari L, Lancranjan I.
    J Clin Endocrinol Metab; 1986 Jul 20; 63(1):266-8. PubMed ID: 3711262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.